TSX Delisting Review - Antibe Therapeutics Inc. (ATE)

April 24, 2024
Issuer: Antibe Therapeutics Inc.
Securities: Common shares (the "Shares")
Symbol(s): ATE
Delisting Date: May 24, 2024 (at the close)
Reason: Failure to meet continued listing requirements.
Trading: The Shares will remain suspended from trading.
Additional Information: TSX Bulletin 2024-0219 dated April 9, 2024.
TSX contact: Selma Thaver,
Managing Director,
TSX Listings